Ceiling effect (pharmacology)
 | This article needs additional citations for verification. (February 2021) |
In pharmacology, the term ceiling effect refers to the property of increasing doses of a given medication to have progressively smaller incremental effect (an example of diminishing returns). Mixed agonist-antagonist opioids, such as nalbuphine, serve as a classic example of the ceiling effect; increasing the dose of a narcotic frequently leads to smaller and smaller gains in relief of pain. In many cases, the severity of side effects from a medication increases as the dose increases, long after its therapeutic ceiling has been reached.
The term is defined as "the phenomenon in which a drug reaches a maximum effect, so that increasing the drug dosage does not increase its effectiveness."[1] Sometimes drugs cannot be compared across a wide range of treatment situations because one drug has a ceiling effect.[citation needed]
Sometimes the desired effect increases with dose, but side effects worsen or start being dangerous, and risk to benefit ratio increases. This is because of occupation of all the receptors in a given specimen.
See also
[edit]- Agonist–antagonist opioids
- Buprenorphine
- Codeine
- Dose–response relationship
- Pain ladder
- Weber–Fechner law
References
[edit]- ^ Baker, Hans (2004). Illustrated Medical Dictionary. Lotus Press. p. 40.
External links
[edit]- Is there a ceiling effect of transdermal buprenorphine? Preliminary data in cancer patients
- Clinical evidence for an LH ‘ceiling’ effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation
- Analgesic effect of i.v. paracetamol: possible ceiling effect of paracetamol in postoperative pain